BIODESIX, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $-225.1M | $5.3M |
| FY2020 | $28.1M | $41.2M | $62.1M |
| FY2021 | $10.1M | $19.7M | $32.7M |
| FY2022 | $30.1M | $20.6M | $43.1M |
| FY2023 | $40.1M | $4.6M | $26.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $-225.1M | $5.3M |
| FY2020 | $28.1M | $41.2M | $62.1M |
| FY2021 | $10.1M | $19.7M | $32.7M |
| FY2022 | $30.1M | $20.6M | $43.1M |
| FY2023 | $40.1M | $4.6M | $26.3M |